Tryptamine Therapeutics Ltd. is a clinical-stage biotechnology company, which engages in investing in biopharmaceutical drug development. The company was headquartered in Camberwell, Australia.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company